RenovoRx Q2 2023 milestones include positive Ph. 3 interim analysis data from the pivotal TIGeR-PaC study and a strategic collaboration with @TeamImugene to deliver oncolytic immunotherapy and expand our platform to help metastatic cancer patients. bit.ly/3OFEajH $RNXT
RenovoRx
567 posts
RenovoRx is developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device. Nasdaq: $RNXT
- .@ContractPharma highlights our collaboration with @TeamImugene to explore the trans-arterial delivery of Imugene’s CF33 oncolytic virus utilizing RenovoRx’s TAMP™ therapy platform. bit.ly/3QkI9V9 $RNXT $IMU #PancreaticCancer #LiverCancer
- $RNXT - Join the RenovoRx CEO, Shaun Bagai at the Roth Capital Partners' 34th Annual Conference on March 14, 1:30 p.m. PT, and at the Maxim Virtual Growth Conference, March 28-30. Learn how to register: Read all about it here: (ow.ly/gpny50Ih4Me) #cancerresearch #LAPC #hope
- RenovoRx Q3 2023 business highlights include the continued advancement of the pivotal Phase III TIGeR-PaC study for the treatment of LAPC and further validation of the TAMP platform through our recent collaboration with @TeamImugene. For more info: bit.ly/3QG7Kqo $RNXT
- RenovoRx is honored to be fighting difficult-to-treat cancers, like pancreatic cancer, with partners like @TeamImugene. We are striving to improve the standard of care for patients diagnosed with #pancreaticcancer. bit.ly/3R0pQ7K #PancreaticCancerAwareness
- The #RenovoRxTeam is proud to have joined the @PanCAN's PurpleStride last Saturday, raising funds/awareness to fight one of the deadliest cancers. To learn more on how we are taking steps to fight this disease, visit pancan.org and renovorx.com #PanCAN
- It's Pancreatic Cancer Awareness Month! RenovoRx is joining @PanCAN in raising awareness about the urgent need for more research. Research for those we've lost. Research for patients. Research for all of us. 📣💜 Learn more at pancan.org/awareness #PanCANawareness #WPCD
- Join our team in supporting @PanCAN to take steps to end pancreatic cancer at the PanCAN PurpleStride. Learn how to register. ➡️ow.ly/7JqB50Im1bQ⬅️ #cancer #breakthroughs #hope #fightingcancer #PanCAN #PurpleStride #pancreaticcancer #PanCANPurpleStride
- Our team was pleased to have joined @PanCAN as a sponsor of the organization’s #PanCANPurpleStride Silicon Valley event last Saturday, April 29th. Learn more: bit.ly/3LJYm3E $RNXT
- RenovoRx today announced the acceptance of a clinical data abstract for the 2024 Society of Interventional Radiology Annual Scientific Meeting, held March 23-28 in Salt Lake City, Utah. bit.ly/3NAWc74 $RNXT #SIR24SLC #PancreaticCancer @SIRspecialists
- Our seventh U.S. patent issuance marks an important achievement in our patent portfolio with its additional coverage for the RenovoRx therapy platform. Read more ow.ly/Lkf350HzW86 #cancer #medicine #fightingcancer #pancreaticcancer #clinicaltrials #intellectualproperty
- Join us at the @MaximGrp LLC Virtual Growth Conference, March 28-30. Shaun Bagai, @RenovoRx CEO, will participate in a panel discussion focused on #PancreaticCancer during the conference. He will discuss how $RNXT is fighting this deadly #cancer...
- DYK more than 64K Americans will be diagnosed with #pancreaticcancer this year? Learn about our unique approach to targeted treatment with the goal of improving quality of life for patients battling difficult-to-treat cancers and extending their survival. bit.ly/3urdTiK
- The RenovoRx team is proud to be participating in @PanCAN's #PanCANPurpleStride on Sat., April 29th to raise awareness for #PancreaticCancer. Join or support our team to help support those affected by pancreatic cancer: bit.ly/3m2xuSq #cancerawareness #cancertreatment














